BridgeBio Pharma (BBIO) delivered earnings and revenue surprises of -34.05% and +2.77%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

While the Dolphins are undergoing a full organization reset, there are two star players Miami is unwilling to part with.

Mental health experts break down some common myths that persist around the experience of therapy.

Planning for phase 1/2 clinical trial initiation in Australia utilizing CYWC628 to treat diabetic foot ulcers in the first half of 2026Improved balance sheet through multiple direct offerings; ...

"It gives me that instant softness and strength," Chloe Fineman raved of the fresh formula.

Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsChinmay Shukla - Senior Vice President of ...

Billions of dollars’ worth of cancer drugs are discarded each year. Manufacturers must refund Medicare for some of this waste ...

The average interest rate on a 30-year, fixed-rate mortgage ticked down to 5.87% APR, according to rates provided to ...

Medtronic delivers business value through product and packaging improvements that conserve natural resources, increase recyclability, and help minimize emissions and waste. NORTHAMPTON, MA / ACCESS Ne ...

Aptose Biosciences Inc. ("Aptose" or the "Company") announced today that it has entered into an amended and restated arrangement agreement dated February 23, 2026 (the "Amended and Restated ...

The Court appointed serving and former judicial officers to adjudicate pending claims under the Special Intensive Revision due to a stalemate between the State Government and ECI. Their directions ...

The power of pop finds new expression in a wave of documentaries, features and high-tech gadgetry that might just leave the album in the dust.